Catalyst Wire Dossier Catalyst Wire Dossier

INVELTYS

LOTEPREDNOL ETABONATE · ALCON LABORATORIES, INC.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INVELTYS, covering 2018-08-22 to 2020-04-24. Get the full timeline:

Most recent: FDA Approved: INVELTYS — Supplemental Application (ALCON LABORATORIES, INC.)

See pricing